"Markets are likely to remain in consolidation mode this week amidst key events including the release of domestic GDP data, monthly expiry, and domestic and global macroeconomic data. Also, around 7% deficit in the Jun-Sept monsoon could keep upside limited," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal Financial Services Ltd
“We feel it is a breather after the recent fall and traders should continue with negative bias in the index. At the same time, a mixed trend on the sectoral front would continue to offer opportunities on both sides so participants should focus on stock selection and maintain a hedged approach,” said Ajit Mishra, SVP - Technical Research, Religare Broking Ltd. Reliance Industries (RIL), Adani Enterprises, Brightcom Group, Gland Pharma among stocks to watch on Tuesday
The absence of any announcements regarding the IPOs of Reliance Retail and Telecom dragged the RIL stock down on Monday. “But indications about the green energy business are positive. Volatility in the stock price on the AGM day is normal for RIL. Announcements regarding value unlocking through IPOs of retail and telecom businesses can come any time,” said VK Vijayakumar, Chief Investment Strategist at Geojit Financial Services
Continue viewing BT Visual Story
Catch the latest business news, share market updates, expert analysis and exclusives only on BTTV.in
Brightcom Group, in an exchange filing on Sunday, announced the resignations of its Chairman and Managing Director (CMD) Suresh Reddy and Chief Financial Officer (CFO) Narayana Raju, amid a crackdown by market regulator Securities and Exchange Board of India (SEBI). The company’s board in a meeting lasting nearly 2 hours, considered and approved the decisions
An investigation of India’s Adani Group by the market regulator has reportedly uncovered violations of rules on disclosures by listed entities and limits on the holdings of offshore funds. The Securities and Exchange Board of India (SEBI) launched the inquiry after the US-based Hindenburg Research raised governance concerns around the Gautam Adani-led group
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, Trandolapril and Verapamil Hydrochloride extended-release tablets, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA)
Shares of Birla Corporation will trade ex-dividend on Tuesday, (August 29). The company has announced a dividend of Rs 2.5 per equity share
"The short-term trend of Nifty remains weak. As long as it trades below 19,400 levels, there is a chance of further weakness down to the next supports of 19,100-19,000 levels. A decisive move above the immediate resistance of 19,370-19,400 could open the next upside towards 19,600 levels for the short term," said Nagaraj Shetti, Technical Research Analyst, HDFC Securities
“The Bank Nifty index displays a robust bullish sentiment at the lower end of the range, with sustained buying interest. As long as the index maintains its hold above the key level of 44,000, the prevailing stance remains on the buy side. An immediate challenge for further upside movement is positioned at 44,500. A successful breach of this level could trigger short covering and drive the index towards 45,000," said Kunal Shah, Senior Technical & Derivative analyst at LKP Securities
Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of Business Today. Investors should consult their financial advisors before taking any position.